Subscribe To
Phio pharmaceuticals presents new data for targeting of brd4 with its intasyl™ compound ph-894
–Preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cel...
October 11, 2023, 11:30 am
Relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023
Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma glucose levels and body weight gain in a mice model ...
October 11, 2023, 8:31 am
Sana biotechnology announces increased focus on hypoimmune-related pipeline with the potential to deliver clinical proof of concept data from four programs in 2023 and 2024 with a 2024 operating burn
Increasing focus on ex vivo cell therapy platform based on extensive preclinical and early translationa...
October 10, 2023, 8:15 pm
Cybrexa therapeutics to debut preclinical data demonstrating cbx-15 is safe and highly efficacious in 13762 triple negative breast cancer model at 35th aacr-nci-eortc symposium
Preclinical Data Demonstrate CBX-15’s Anti-Tumor Efficacy in Animal Models and Ability to Enhance Imm...
October 10, 2023, 12:05 pm
Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023
SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...
October 9, 2023, 4:10 pm
Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023
SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immun...
October 9, 2023, 12:10 pm
Agenus: getting the tough decisions right with catalysts ahead
AGEN has chosen to focus its efforts on botensilimab and balstilimab, postponing its other clinical and precli...
October 6, 2023, 6:38 pm
Athira pharma presents preclinical data further supporting the therapeutic potential of ath-1105 in amyotrophic lateral sclerosis (als)
New results support the neuroprotective effects of ATH-1105 in preclinical models of ALS, as indicated ...
October 5, 2023, 8:30 pm
Neurona therapeutics announces publication in cell stem cell reporting the development of investigational novel regenerative cell therapy strategy for drug-resistant focal epilepsy
Publication demonstrates robust and reproducible generation of pure pallial, medial ganglionic eminence (MGE)-type GABAergic inhibitory interneuron ce...
October 5, 2023, 3:00 pm
Immuneering to present preclinical data on imm-1-104 and imm-6-415 at aacr-nci-eortc international conference on molecular targets and cancer therapeutics
CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for...
October 4, 2023, 4:05 pm
Omega therapeutics to present new preclinical data on otx-2101 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pion...
October 4, 2023, 4:00 pm
Black diamond therapeutics to present preclinical and clinical data at the aacr-nci-eortc international conference on molecular targets and cancer therapeutics
CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...
October 4, 2023, 12:14 pm
Kura oncology announces three presentations at aacr-nci-eortc international conference on molecular targets and cancer therapeutics
– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapi...
October 4, 2023, 11:30 am
$vktx: consolidation in viking therapeutics provides an opportunity
Viking Therapeutics Inc. is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases. Metabolic and rare...
October 2, 2023, 6:17 pm
Candel therapeutics announces three abstracts accepted for poster presentations at sitc 2023 annual meeting
One clinical poster detailing initial overall survival and immunological biomarker data from the ongoing, randomized, open-label phase 2 clinical tria...
September 27, 2023, 1:40 pm
Allogene therapeutics announces three poster presentations from its next generation allocar t™ platform at the society for immunotherapy of cancer (sitc) annual meeting
Spotlight on Novel, Targeted Technologies to Enhance Engraftment, Expansion and Persistence of AlloCAR T™ Cells Demonstration of Dagger™ Technolog...
September 27, 2023, 1:09 pm
Crispr therapeutics to present at the society for immunotherapy of cancer (sitc) 38th annual meeting
ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating tr...
September 27, 2023, 9:01 am
Transcode therapeutic stock whipsaws lower after cut price placing
TransCode Therapeutics (NASDAQ:RNAZ) stock has seen a wild 24 hours of trading as the Boston headquartered nano-cap drug discovery firm rocketed Monda...
September 26, 2023, 6:47 am
Kineta to present new preclinical data on lead anti-cd27 agonist antibody at aacr special conference on tumor immunology and immunotherapy
SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...
September 25, 2023, 9:30 am
Novo nordisk partners with valo health on ai drug discovery
Novo Nordisk NVO, +0.01% on Monday announced a partnership with Valo Health Inc., a technology company specializing in AI-powered drug discovery and d...
September 25, 2023, 8:28 am